Cas:950845-96-2 1-N-(5-bromopyrazin-2-yl)-4-methoxybenzene-1,2-diamine manufacturer & supplier

Chemical Name:1-N-(5-bromopyrazin-2-yl)-4-methoxybenzene-1,2-diamine

CAS.NO:950845-96-2

Synonyms:QC-6949;N1-(5-bromopyrazin-2-yl)-4-methoxybenzene-1,2-diamine;1,2-Benzenediamine, N-(5-bromo-2-pyrazinyl)-4-methoxy-;N-(5-BROMOPYRAZIN-2-YL)-2-AMINO-4-METHOXYANILINE;N-(5-Bromopyrazin-2-yl)-4-methoxybenzene-1,2-diamine;N-(5-Bromo-2-pyrazinyl)-4-methoxy-1,2-benzenediamine

Molecular Formula:C₁₁H₁₁BrN₄O

Molecular Weight:295.135

HS Code:2933990090

Physical and Chemical Properties:

Melting point:N/A

Boiling point:414.6±45.0 °C at 760 mmHg

Density:1.6±0.1 g/cm3

Index of Refraction:1.689

PSA:73.06000

Exact Mass:294.011627

LogP:2.50

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like QC-6949 chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,N-(5-Bromo-2-pyrazinyl)-4-methoxy-1,2-benzenediamine physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,QC-6949 Use and application,1,2-Benzenediamine, N-(5-bromo-2-pyrazinyl)-4-methoxy- technical grade,usp/ep/jp grade.

Related News: More than 2,000 new cases were also recorded in the country in the past 24 hours, raising the worldwide total to nearly 14,380, according to Chinese and World Health Organization data. The vast majority of the cases are inside China; about 100 cases have been confirmed in at least 23 other countries. 1-N-(5-bromopyrazin-2-yl)-4-methoxybenzene-1,2-diamine manufacturer Vietnam recently barred almost all flights to and from mainland China, Hong Kong and Macau until May 1, according to the United States Federal Aviation Administration. 1-N-(5-bromopyrazin-2-yl)-4-methoxybenzene-1,2-diamine supplier For example, there are concerns that PFAS’ effect on the thyroid could lead to thyroid cancer, van Gerwen said. 1-N-(5-bromopyrazin-2-yl)-4-methoxybenzene-1,2-diamine vendor Novavax, a Maryland biotechnology company that has struggled mightily with delays in developing its coronavirus vaccine, announced Monday that its two-shot regimen was over 90% effective overall in a trial that unfolded even as more contagious variants emerged. 1-N-(5-bromopyrazin-2-yl)-4-methoxybenzene-1,2-diamine factory Novavax, a Maryland biotechnology company that has struggled mightily with delays in developing its coronavirus vaccine, announced Monday that its two-shot regimen was over 90% effective overall in a trial that unfolded even as more contagious variants emerged.